The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives.

We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials.

When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.

Health Care

Life Sciences

Non Profit

Pharmaceutical

Research

Drugs for Neglected Diseases initiative - DNDi

Dr Luis Pizarro

Dominique Junod Moser

Pascal Carpentier

Wendy Keller

James Arkinstall

Ilan Moss

Phoutthasone Bouppha

Laurence Vielfaure

Nathalie Strub Wourgaft

Melchias Mukendi Ilunga

The Clinical Research and Development Team at the Drugs for Neglected Diseases initiative (DNDi) oversees the design, implementation, and management of clinical trials for new treatments targeting neglected diseases such as Chagas disease, sleeping sickness, and leishmaniasis. This includes ensuring the quality and integrity of data, compliance with regulatory standards, and the successful coordination of international research collaborations to advance drug development for underserved patient populations.

Clinical Research and Development Team

Communications and External Relations

Finance Team

Clinical Research and Development Team

About

Team members

Other teams at Drugs for Neglected Diseases initiative - DNDi

Communications and External Relations

Finance Team